UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Fiduciary Alliance LLC

Fiduciary Alliance LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 260.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,893 shares of the healthcare conglomerate’s stock after acquiring an additional 7,150 shares during the quarter. Fiduciary Alliance LLC’s holdings in UnitedHealth Group were worth $5,005,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. State Street Corp raised its stake in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC lifted its position in UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after acquiring an additional 318,039 shares during the period. Franklin Resources Inc. raised its stake in shares of UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares in the last quarter. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 4.1 %

UNH traded up $21.59 during trading on Monday, hitting $542.28. The company had a trading volume of 1,345,160 shares, compared to its average volume of 3,737,545. The firm’s 50-day moving average price is $555.25 and its 200 day moving average price is $562.50. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $499.05 billion, a PE ratio of 35.33, a PEG ratio of 1.53 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.56 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

Several research firms have recently weighed in on UNH. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.